Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

410
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
410
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

133
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
133
Drug Therapy01:28

Drug Therapy

108
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
108
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

157
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
157

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cultural adaptation and psychometric validation of the Health Literacy Instrument for Adults with Tuberculosis (HELIA-TB) in India.

PloS one·2026
Same author

Translating the Living with Medicines Questionnaire from English to Swedish: a validation study.

Scandinavian journal of public health·2026
Same author

Promoting Positive Youth Development with Adolescent Boys in UK Schools: A Theory-Driven Evaluation of the "Becoming a Man" Programme.

Journal of prevention (2022)·2025
Same author

Endoscopic Retrograde Cholangiopancreatography (ERCP) services across the UK.

Gut·2025
Same author

An analysis of NHS 111 demand for primary care services: A retrospective cohort study.

PloS one·2024
Same author

Modelling NHS England 111 demand for primary care services: a discrete event simulation.

BMJ open·2023

Related Experiment Video

Updated: Sep 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Can agent-based simulation be used as a tool to support polypharmacy prescribing practice?

Daniel Chalk1, Sean Manzi1, Nicky Britten1

  • 1NIHR CLAHRC for the South West Peninsula, St Luke’s Campus, University of Exeter Medical School, Exeter, UK.

BMJ Simulation & Technology Enhanced Learning
|May 6, 2022
PubMed
Summary
This summary is machine-generated.

A new simulation model helps understand why patients with type 2 diabetes and asthma miss medications. This tool predicts adherence and effectiveness for complex medication regimens.

Keywords:
Agent Based Simulation

More Related Videos

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

1.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Related Experiment Videos

Last Updated: Sep 24, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

1.1K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Area of Science:

  • Health Services Research
  • Computational Modeling
  • Behavioral Science

Background:

  • Polypharmacy, the use of multiple medications, is common in patients with type 2 diabetes and asthma.
  • Non-adherence to prescribed medication regimens can negatively impact treatment outcomes for these conditions.

Purpose of the Study:

  • To develop a simulation modeling method to understand factors influencing medication adherence in patients with type 2 diabetes and asthma on polypharmacy.
  • To create a proof-of-concept agent-based simulation model to predict adherence and clinical effectiveness.

Main Methods:

  • Collaborative development of a factor map with patients, general practitioners, pharmacists, and researchers.
  • Translation of behavioral influences into logical rules based on literature data.
  • Construction of an agent-based simulation model to simulate medicine-taking behaviors.

Main Results:

  • A model was developed that maps factors affecting medication-taking decisions in polypharmacy patients.
  • The agent-based model simulates medicine-taking behaviors for type 2 diabetes and asthma medications.
  • The model predicts clinical effectiveness and adherence rates for various medication combinations.

Conclusions:

  • The developed simulation model can serve as a prescription support tool.
  • The model can be utilized to estimate medicine-taking behavior in cost-effectiveness analyses.
  • This approach offers a novel method for understanding and predicting adherence in complex medication scenarios.